Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Apr;73(4):889–897. doi: 10.1172/JCI111312

The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.

R A Lewis, K F Austen
PMCID: PMC425099  PMID: 6323538

Full text

PDF
894

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON F., Jr, SMITH M. R., WOOD W. B., Jr Studies on the pathogenesis of acute inflammation. I. The inflammatory reaction to thermal injury as observed in the rabbit ear chamber. J Exp Med. 1955 Dec 1;102(6):655–668. doi: 10.1084/jem.102.6.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson M. E., Allison R. D., Meister A. Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1088–1091. doi: 10.1073/pnas.79.4.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Austen K. F., Corey E. J., Drazen J. M., Leitch A. G. The effect of indomethacin on the contractile response of the guinea-pig lung parenchymal strip to leukotrienes B4, C4, D4 and E4. Br J Pharmacol. 1983 Sep;80(1):47–53. doi: 10.1111/j.1476-5381.1983.tb11048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BROCKLEHURST W. E. Occurrence of an unidentified substance during anaphylactic shock in cavy lung. J Physiol. 1953 Apr 28;120(1-2):16P–17P. [PubMed] [Google Scholar]
  5. BROCKLEHURST W. E. Slow reacting substance and related compounds. Prog Allergy. 1962;6:539–558. [PubMed] [Google Scholar]
  6. Bach M. K., Brashler J. R., Smith H. W., Fitzpatrick F. A., Sun F. F., McGuire J. C. 6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies. Prostaglandins. 1982 May;23(5):759–771. [PubMed] [Google Scholar]
  7. Bell R. L., Kennerly D. A., Stanford N., Majerus P. W. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3238–3241. doi: 10.1073/pnas.76.7.3238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bernström K., Hammarström S. Metabolism of leukotriene D by porcine kidney. J Biol Chem. 1981 Sep 25;256(18):9579–9582. [PubMed] [Google Scholar]
  9. Borgeat P., Hamberg M., Samuelsson B. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. J Biol Chem. 1976 Dec 25;251(24):7816–7820. [PubMed] [Google Scholar]
  10. Borgeat P., Picard S., Vallerand P., Sirois P. Transformation of arachidonic acid in leukocytes. Isolation and structural analysis of a novel dihydroxy derivative. Prostaglandins Med. 1981 Jun;6(6):557–570. doi: 10.1016/0161-4630(81)90117-8. [DOI] [PubMed] [Google Scholar]
  11. Borgeat P., Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid. J Biol Chem. 1979 Apr 25;254(8):2643–2646. [PubMed] [Google Scholar]
  12. Boushey H. A., Holtzman M. J., Sheller J. R., Nadel J. A. Bronchial hyperreactivity. Am Rev Respir Dis. 1980 Feb;121(2):389–413. doi: 10.1164/arrd.1980.121.2.389. [DOI] [PubMed] [Google Scholar]
  13. Bruns R. F., Thomsen W. J., Pugsley T. A. Binding of leukotrienes C4 and D4 to membranes from guinea pig lung: regulation by ions and guanine nucleotides. Life Sci. 1983 Aug 15;33(7):645–653. doi: 10.1016/0024-3205(83)90253-9. [DOI] [PubMed] [Google Scholar]
  14. Burke J. A., Levi R., Guo Z. G., Corey E. J. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther. 1982 Apr;221(1):235–241. [PubMed] [Google Scholar]
  15. Claesson H. E. Leukotrienes A4 and B4 stimulate the formation of cyclic AMP in human leukocytes. FEBS Lett. 1982 Mar 22;139(2):305–308. doi: 10.1016/0014-5793(82)80876-4. [DOI] [PubMed] [Google Scholar]
  16. Coles S. J., Neill K. H., Reid L. M., Austen K. F., Nii Y., Corey E. J., Lewis R. A. Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa. Prostaglandins. 1983 Feb;25(2):155–170. doi: 10.1016/0090-6980(83)90101-6. [DOI] [PubMed] [Google Scholar]
  17. Cromwell O., Walport M. J., Morris H. R., Taylor G. W., Hodson M. E., Batten J., Kay A. B. Identification of leukotrienes D and B in sputum from cystic fibrosis patients. Lancet. 1981 Jul 25;2(8239):164–165. doi: 10.1016/s0140-6736(81)90353-6. [DOI] [PubMed] [Google Scholar]
  18. Dahlén S. E., Björk J., Hedqvist P., Arfors K. E., Hammarström S., Lindgren J. A., Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3887–3891. doi: 10.1073/pnas.78.6.3887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Davidson E. M., Rae S. A., Smith M. J. Leukotriene B4 in synovial fluid. J Pharm Pharmacol. 1982 Jun;34(6):410–410. doi: 10.1111/j.2042-7158.1982.tb04745.x. [DOI] [PubMed] [Google Scholar]
  20. Drazen J. M., Austen K. F. Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2alpha on pulmonary mechanics in the guinea pig. J Clin Invest. 1974 Jun;53(6):1679–1685. doi: 10.1172/JCI107719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Drazen J. M., Austen K. F., Lewis R. A., Clark D. A., Goto G., Marfat A., Corey E. J. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4354–4358. doi: 10.1073/pnas.77.7.4354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Drazen J. M., Lewis R. A., Austen K. F., Toda M., Brion F., Marfat A., Corey E. J. Contractile activities of structural analogs of leukotrienes C and D: necessity of a hydrophobic region. Proc Natl Acad Sci U S A. 1981 May;78(5):3195–3198. doi: 10.1073/pnas.78.5.3195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Drazen J. M., Lewis R. A., Austen K. F., Toda M., Brion F., Marfat A., Corey E. J. Contractile activities of structural analogs of leukotrienes C and D: necessity of a hydrophobic region. Proc Natl Acad Sci U S A. 1981 May;78(5):3195–3198. doi: 10.1073/pnas.78.5.3195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Drazen J. M., Venugopalan C. S., Austen K. F., Brion F., Corey E. J. Effects of leukotriene E on pulmonary mechanics in the guinea pig. Am Rev Respir Dis. 1982 Mar;125(3):290–294. doi: 10.1164/arrd.1982.125.3.290. [DOI] [PubMed] [Google Scholar]
  25. Fels A. O., Pawlowski N. A., Cramer E. B., King T. K., Cohn Z. A., Scott W. A. Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7866–7870. doi: 10.1073/pnas.79.24.7866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Fitzpatrick F., Haeggström J., Granström E., Samuelsson B. Metabolism of leukotriene A4 by an enzyme in blood plasma: a possible leukotactic mechanism. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5425–5429. doi: 10.1073/pnas.80.17.5425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  28. Gill S. S., Hammock B. D. Hydration of cis- and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver. Biochem Biophys Res Commun. 1979 Aug 13;89(3):965–971. doi: 10.1016/0006-291x(79)91872-2. [DOI] [PubMed] [Google Scholar]
  29. Goetzl E. J., Pickett W. C. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol. 1980 Oct;125(4):1789–1791. [PubMed] [Google Scholar]
  30. Goetzl E. J., Sun F. F. Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils. J Exp Med. 1979 Aug 1;150(2):406–411. doi: 10.1084/jem.150.2.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Goetzl E. J. The conversion of leukotriene C4 to isomers of leukotriene B4 by human eosinophil peroxidase. Biochem Biophys Res Commun. 1982 May 31;106(2):270–275. doi: 10.1016/0006-291x(82)91105-6. [DOI] [PubMed] [Google Scholar]
  32. Goldman D. W., Goetzl E. J. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J Immunol. 1982 Oct;129(4):1600–1604. [PubMed] [Google Scholar]
  33. Griffin M., Weiss J. W., Leitch A. G., McFadden E. R., Jr, Corey E. J., Austen K. F., Drazen J. M. Effects of leukotriene D on the airways in asthma. N Engl J Med. 1983 Feb 24;308(8):436–439. doi: 10.1056/NEJM198302243080807. [DOI] [PubMed] [Google Scholar]
  34. Guenthner T. M., Hammock B. D., Vogel U., Oesch F. Cytosolic and microsomal epoxide hydrolases are immunologically distinguishable from each other in the rat and mouse. J Biol Chem. 1981 Apr 10;256(7):3163–3166. [PubMed] [Google Scholar]
  35. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hansson G., Lindgren J. A., Dahlén S. E., Hedqvist P., Samuelsson B. Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett. 1981 Jul 20;130(1):107–112. doi: 10.1016/0014-5793(81)80676-x. [DOI] [PubMed] [Google Scholar]
  37. Henderson W. R., Jörg A., Klebanoff S. J. Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. J Immunol. 1982 Jun;128(6):2609–2613. [PubMed] [Google Scholar]
  38. Holroyde M. C., Altounyan R. E., Cole M., Dixon M., Elliott E. V. Bronchoconstriction produced in man by leukotrienes C and D. Lancet. 1981 Jul 4;2(8236):17–18. doi: 10.1016/s0140-6736(81)90254-3. [DOI] [PubMed] [Google Scholar]
  39. Ishizaka T., Ishizaka K., Orange R. P., Austen K. F. Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J Immunol. 1971 May;106(5):1267–1273. [PubMed] [Google Scholar]
  40. Jakschik B. A., Harper T., Murphy R. C. Leukotriene C4 and D4 formation by particulate enzymes. J Biol Chem. 1982 May 25;257(10):5346–5349. [PubMed] [Google Scholar]
  41. Jones T., Masson P., Hamel R., Brunet G., Holme G., Girard Y., Larue M., Rokach J. Biological activity of leukotriene sulfones on respiratory tissues. Prostaglandins. 1982 Aug;24(2):279–291. doi: 10.1016/0090-6980(82)90154-x. [DOI] [PubMed] [Google Scholar]
  42. Klickstein L. B., Shapleigh C., Goetzl E. J. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest. 1980 Nov;66(5):1166–1170. doi: 10.1172/JCI109947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kreisle R. A., Parker C. W. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes. J Exp Med. 1983 Feb 1;157(2):628–641. doi: 10.1084/jem.157.2.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Krilis S., Lewis R. A., Corey E. J., Austen K. F. Bioconversion of C-6 sulfidopeptide leukotrienes by the responding guinea pig ileum determines the time course of its contraction. J Clin Invest. 1983 Apr;71(4):909–915. doi: 10.1172/JCI110845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Krilis S., Lewis R. A., Corey E. J., Austen K. F. Specific receptors for leukotriene C4 on a smooth muscle cell line. J Clin Invest. 1983 Oct;72(4):1516–1519. doi: 10.1172/JCI111109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Lee C. W., Lewis R. A., Corey E. J., Austen K. F. Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. Immunology. 1983 Jan;48(1):27–35. [PMC free article] [PubMed] [Google Scholar]
  47. Lee C. W., Lewis R. A., Corey E. J., Barton A., Oh H., Tauber A. I., Austen K. F. Oxidative inactivation of leukotriene C4 by stimulated human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4166–4170. doi: 10.1073/pnas.79.13.4166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Lee C. W., Lewis R. A., Tauber A. I., Mehrotra M., Corey E. J., Austen K. F. The myeloperoxidase-dependent metabolism of leukotrienes C4, D4, and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. J Biol Chem. 1983 Dec 25;258(24):15004–15010. [PubMed] [Google Scholar]
  49. Leitch A. G., Corey E. J., Austen K. F., Drazen J. M. Indomethacin potentiates the pulmonary response to aerosol leukotriene C4 in the guinea pig. Am Rev Respir Dis. 1983 Oct;128(4):639–643. doi: 10.1164/arrd.1983.128.4.639. [DOI] [PubMed] [Google Scholar]
  50. Lewis R. A., Drazen J. M., Austen K. F., Clark D. A., Corey E. J. Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. Biochem Biophys Res Commun. 1980 Sep 16;96(1):271–277. doi: 10.1016/0006-291x(80)91210-3. [DOI] [PubMed] [Google Scholar]
  51. Lewis R. A., Drazen J. M., Austen K. F., Toda M., Brion F., Marfat A., Corey E. J. Contractile activities of structural analogs of leukotrienes C and D: role of the polar substituents. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4579–4583. doi: 10.1073/pnas.78.7.4579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Lewis R. A., Lee C. W., Levine L., Morgan R. A., Weiss J. W., Drazen J. M., Oh H., Hoover D., Corey E. J., Austen K. F. Biology of the C-6-sulfidopeptide leukotrienes. Adv Prostaglandin Thromboxane Leukot Res. 1983;11:15–26. [PubMed] [Google Scholar]
  53. Lewis R. A., Soter N. A., Diamond P. T., Austen K. F., Oates J. A., Roberts L. J., 2nd Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol. 1982 Oct;129(4):1627–1631. [PubMed] [Google Scholar]
  54. Maas R. L., Turk J., Oates J. A., Brash A. R. Formation of a novel dihydroxy acid from arachidonic acid by lipoxygenase-catalyzed double oxygenation in rat mononuclear cells and human leukocytes. J Biol Chem. 1982 Jun 25;257(12):7056–7067. [PubMed] [Google Scholar]
  55. Marone G., Kagey-Sobotka A., Lichtenstein L. M. Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. J Immunol. 1979 Oct;123(4):1669–1677. [PubMed] [Google Scholar]
  56. Mathews W. R., Murphy R. C. Inhibition of leukotriene biosynthesis in mastocytoma cells by diethylcarbamazine. Biochem Pharmacol. 1982 Jun 1;31(11):2129–2132. doi: 10.1016/0006-2952(82)90435-x. [DOI] [PubMed] [Google Scholar]
  57. Maycock A. L., Anderson M. S., DeSousa D. M., Kuehl F. A., Jr Leukotriene A4: preparation and enzymatic conversion in a cell-free system to leukotriene B4. J Biol Chem. 1982 Dec 10;257(23):13911–13914. [PubMed] [Google Scholar]
  58. McKean M. L., Smith J. B., Silver M. J. Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid. J Biol Chem. 1981 Feb 25;256(4):1522–1524. [PubMed] [Google Scholar]
  59. Mencia-Huerta J. M., Razin E., Ringel E. W., Corey E. J., Hoover D., Austen K. F., Lewis R. A. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. J Immunol. 1983 Apr;130(4):1885–1890. [PubMed] [Google Scholar]
  60. Michelassi F., Landa L., Hill R. D., Lowenstein E., Watkins W. D., Petkau A. J., Zapol W. M. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science. 1982 Aug 27;217(4562):841–843. doi: 10.1126/science.6808665. [DOI] [PubMed] [Google Scholar]
  61. Morgenstern R., Guthenberg C., Depierre J. W. Microsomal glutathione S-transferase. Purification, initial characterization and demonstration that it is not identical to the cytosolic glutathione S-transferases A, B and C. Eur J Biochem. 1982 Nov;128(1):243–248. [PubMed] [Google Scholar]
  62. Murphy R. C., Hammarström S., Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4275–4279. doi: 10.1073/pnas.76.9.4275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Murphy R. C., Pickett W. C., Culp B. R., Lands W. E. Tetraene and pentaene leukotrienes: selective production from murine mastocytoma cells after dietary manipulation. Prostaglandins. 1981 Oct;22(4):613–622. doi: 10.1016/0090-6980(81)90070-8. [DOI] [PubMed] [Google Scholar]
  64. Naccache P. H., Sha'afi R. I., Borgeat P., Goetzl E. J. Mono- and dihydroxyeicosatetraenoic acids alter calcium homeostasis in rabbit neutrophils. J Clin Invest. 1981 May;67(5):1584–1587. doi: 10.1172/JCI110191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Ochi K., Yoshimoto T., Yamamoto S., Taniguchi K., Miyamoto T. Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes. Activation by adenosine 5'-triphosphate. J Biol Chem. 1983 May 10;258(9):5754–5758. [PubMed] [Google Scholar]
  66. Oliw E. H., Guengerich F. P., Oates J. A. Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem. 1982 Apr 10;257(7):3771–3781. [PubMed] [Google Scholar]
  67. Orange R. P., Austen K. F. Pharmacologic dissociation of immunologic release of histamine and slow reacting substance of anaphylaxis in rats. Proc Soc Exp Biol Med. 1968 Dec;129(3):836–841. doi: 10.3181/00379727-129-33437. [DOI] [PubMed] [Google Scholar]
  68. Orange R. P., Austen W. G., Austen K. F. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate. J Exp Med. 1971 Sep 1;134(3 Pt 2):136s–148s. [PubMed] [Google Scholar]
  69. Orange R. P., Murphy R. C., Austen K. F. Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases. J Immunol. 1974 Jul;113(1):316–322. [PubMed] [Google Scholar]
  70. Orange R. P., Murphy R. C., Karnovsky M. L., Austen K. F. The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J Immunol. 1973 Mar;110(3):760–770. [PubMed] [Google Scholar]
  71. Orange R. P., Valentine M. D., Austen K. F. Inhibition of the release of slow-reacting substance of anaphylaxis in the rat with diethylcarbamazine. Proc Soc Exp Biol Med. 1968 Jan;127(1):127–132. doi: 10.3181/00379727-127-32638. [DOI] [PubMed] [Google Scholar]
  72. Orning L., Hammarström S. Kinetics of the conversion of leukotriene C by gamma-glutamyl transpeptidase. Biochem Biophys Res Commun. 1982 Jun 30;106(4):1304–1309. doi: 10.1016/0006-291x(82)91255-4. [DOI] [PubMed] [Google Scholar]
  73. Orning L., Hammarström S., Samuelsson B. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2014–2017. doi: 10.1073/pnas.77.4.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Parker C. W., Aykent S. Calcium stimulation of the 5-lipoxygenase from RBL-1 cells. Biochem Biophys Res Commun. 1982 Dec 15;109(3):1011–1016. doi: 10.1016/0006-291x(82)92040-x. [DOI] [PubMed] [Google Scholar]
  75. Parker C. W., Koch D., Huber M. M., Falkenhein S. F. Formation of the cysteinyl form of slow reacting substance (leukotriene E4) in human plasma. Biochem Biophys Res Commun. 1980 Dec 16;97(3):1038–1046. doi: 10.1016/0006-291x(80)91480-1. [DOI] [PubMed] [Google Scholar]
  76. Pavek K. Anaphylactic shock in the monkey: its hemodynamics and mediators. Acta Anaesthesiol Scand. 1977;21(4):293–307. doi: 10.1111/j.1399-6576.1977.tb01222.x. [DOI] [PubMed] [Google Scholar]
  77. Peters S. P., Kagey-Sobotka A., MacGlashan D. W., Jr, Siegel M. I., Lichtenstein L. M. The modulation of human basophil histamine release by products of the 5-lipoxygenase pathway. J Immunol. 1982 Aug;129(2):797–803. [PubMed] [Google Scholar]
  78. Pfeffer M. A., Pfeffer J. M., Lewis R. A., Braunwald E., Corey E. J., Austen K. F. Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat. Am J Physiol. 1983 Apr;244(4):H628–H633. doi: 10.1152/ajpheart.1983.244.4.H628. [DOI] [PubMed] [Google Scholar]
  79. Piper P. J., Samhoun M. N. The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat. Prostaglandins. 1981 May;21(5):793–803. doi: 10.1016/0090-6980(81)90236-7. [DOI] [PubMed] [Google Scholar]
  80. Pong S. S., DeHaven R. N., Kuehl F. A., Jr, Egan R. W. Leukotriene C4 binding to rat lung membranes. J Biol Chem. 1983 Aug 25;258(16):9616–9619. [PubMed] [Google Scholar]
  81. Rae S. A., Davidson E. M., Smith M. J. Leukotriene B4, an inflammatory mediator in gout. Lancet. 1982 Nov 20;2(8308):1122–1124. doi: 10.1016/s0140-6736(82)92785-4. [DOI] [PubMed] [Google Scholar]
  82. Rao C. V., Mitra S. B. Distribution of PGE and PGF2 alpha receptor proteins in the intracellular organelles of bovine corpora lutea. Methods Enzymol. 1982;86:192–202. doi: 10.1016/0076-6879(82)86190-9. [DOI] [PubMed] [Google Scholar]
  83. Razin E., Mencia-Huerta J. M., Lewis R. A., Corey E. J., Austen K. F. Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4665–4667. doi: 10.1073/pnas.79.15.4665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Razin E., Mencia-Huerta J. M., Stevens R. L., Lewis R. A., Liu F. T., Corey E., Austen K. F. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med. 1983 Jan 1;157(1):189–201. doi: 10.1084/jem.157.1.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Rådmark O., Malmsten C., Samuelsson B., Goto G., Marfat A., Corey E. J. Leukotriene A. Isolation from human polymorphonuclear leukocytes. J Biol Chem. 1980 Dec 25;255(24):11828–11831. [PubMed] [Google Scholar]
  86. Samuelsson B., Goldyne M., Granström E., Hamberg M., Hammarström S., Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997–1029. doi: 10.1146/annurev.bi.47.070178.005025. [DOI] [PubMed] [Google Scholar]
  87. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983 May 6;220(4597):568–575. doi: 10.1126/science.6301011. [DOI] [PubMed] [Google Scholar]
  88. Smedegård G., Hedqvist P., Dahlén S. E., Revenäs B., Hammarström S., Samuelsson B. Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey. Nature. 1982 Jan 28;295(5847):327–329. doi: 10.1038/295327a0. [DOI] [PubMed] [Google Scholar]
  89. Sok D. E., Han C. Q., Pai J. K., Sih C. J. Inhibition of leukotriene biosynthesis by acetylenic analogs. Biochem Biophys Res Commun. 1982 Jul 16;107(1):101–108. doi: 10.1016/0006-291x(82)91675-8. [DOI] [PubMed] [Google Scholar]
  90. Soter N. A., Lewis R. A., Corey E. J., Austen K. F. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol. 1983 Feb;80(2):115–119. doi: 10.1111/1523-1747.ep12531738. [DOI] [PubMed] [Google Scholar]
  91. Stenmark K. R., James S. L., Voelkel N. F., Toews W. H., Reeves J. T., Murphy R. C. Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med. 1983 Jul 14;309(2):77–80. doi: 10.1056/NEJM198307143090204. [DOI] [PubMed] [Google Scholar]
  92. Stenson W. F., Parker C. W. Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J Immunol. 1980 May;124(5):2100–2104. [PubMed] [Google Scholar]
  93. Strandberg K., Uvnäs B. Purification and properties of the slow reacting substance formed in the cat paw perfused with compound 48-80. Acta Physiol Scand. 1971 Jul;82(3):358–374. doi: 10.1111/j.1748-1716.1971.tb04977.x. [DOI] [PubMed] [Google Scholar]
  94. TOWNLEY R. G., DENNIS M., ITKIN I. H. COMPARATIVE ACTION ON ACETYL-BETA-METHYLCHOLINE, HISTAMINE, AND POLLEN ANTIGENS IN SUBJECTS WITH HAY FEVER AND PATIENTS WITH BRONCHIAL ASTHMA. J Allergy. 1965 Mar-Apr;36:121–137. doi: 10.1016/0021-8707(65)90161-9. [DOI] [PubMed] [Google Scholar]
  95. Turnbull L. S., Turnbull L. W., Leitch A. G., Crofton J. W., Kay A. B. Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma. Lancet. 1977 Sep 10;2(8037):526–529. doi: 10.1016/s0140-6736(77)90664-x. [DOI] [PubMed] [Google Scholar]
  96. Vargaftig B. B., Lefort J., Murphy R. C. Inhibition by aspirin of bronchoconstriction due to leukotrienes C4 and D4 in the guinea pig. Eur J Pharmacol. 1981 Jul 10;72(4):417–418. doi: 10.1016/0014-2999(81)90589-6. [DOI] [PubMed] [Google Scholar]
  97. Warholm M., Guthenberg C., Mannervik B. Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. Biochemistry. 1983 Jul 19;22(15):3610–3617. doi: 10.1021/bi00284a011. [DOI] [PubMed] [Google Scholar]
  98. Wasserman S. I., Austen K. F. Identification and characterization of arylsulfatase A and B of the rat basophil leukemia tumor. J Biol Chem. 1977 Oct 25;252(20):7074–7080. [PubMed] [Google Scholar]
  99. Wasserman S. I., Goetzl E. J., Austen K. F. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol. 1975 Feb;114(2 Pt 1):645–649. [PubMed] [Google Scholar]
  100. Weiss J. W., Drazen J. M., Coles N., McFadden E. R., Jr, Weller P. F., Corey E. J., Lewis R. A., Austen K. F. Bronchoconstrictor effects of leukotriene C in humans. Science. 1982 Apr 9;216(4542):196–198. doi: 10.1126/science.7063880. [DOI] [PubMed] [Google Scholar]
  101. Weiss J. W., Drazen J. M., McFadden E. R., Jr, Weller P., Corey E. J., Lewis R. A., Austen K. F. Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. JAMA. 1983 May 27;249(20):2814–2817. [PubMed] [Google Scholar]
  102. Weller P. F., Lee C. W., Foster D. W., Corey E. J., Austen K. F., Lewis R. A. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7626–7630. doi: 10.1073/pnas.80.24.7626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Whitaker M. O., Wyche A., Fitzpatrick F., Sprecher H., Needleman P. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5919–5923. doi: 10.1073/pnas.76.11.5919. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES